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Abstract
Objective—Quality of life (QoL) for women with gynecologic malignancies is predictive of
chemotherapy related toxicity and overall survival but has not been studied in relation to surgical
outcomes and hospital readmissions. Our goal was to evaluate the association between baseline,
pre-operative QoL measures and 30-day post-operative morbidity and health resource utilization
by gynecologic oncology patients.
Methods—We analyzed prospectively collected survey data from an institution-wide cohort
study. Patients were enrolled from 8/2012 – 6/2013 and medical records data was abstracted
(demographics, comorbid conditions, and operative outcomes). Responses from several validated
health-related QoL instruments were collected. Bivariate tests and multivariable linear and logistic
regression models were used to evaluate factors associated with QoL scores.
Results—Of 182 women with suspected gynecologic malignancies, 152 (84%) were surveyed
pre-operatively and 148 (81%) underwent surgery. Uterine (94; 63.5%), ovarian (26; 17.5%),
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cervical (15; 10%), vulvar/vaginal (8; 5.4%), and other (5; 3.4%) cancers were represented. There
were 37 (25%) cases of postoperative morbidity (PM), 18 (12%) unplanned ER visits, 9(6%)
unplanned clinic visits, and 17 (11.5%) hospital readmissions(HR) within 30 days of surgery. On
adjusted analysis, lower functional well-being scores resulted in increased odds of PM (OR 1.07,
95%CI 1.01-.1.21) and HR (OR 1.11, 95%CI 1.03-1.19). A subjective global assessment score
was also strongly associated with HR (OR 1.89, 95%CI 1.14, 3.16).
Conclusion—Lower pre-operative QoL scores are significantly associated with post-operative
morbidity and hospital readmission in gynecologic cancer patients. This relationship may be a
novel indicator of operative risk.
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Quality of life; Surgical complications; Postoperative recovery
Introduction
The primary treatment modality for many gynecologic malignancies is surgery, often
followed by adjuvant chemotherapy and/or radiation. Surgery is often radical, with
perioperative complication rates of up to 50% depending on cancer site (1-4). In addition,
gynecologic oncology patients are frequently surgically and medically complex, which
compounds surgical risk. This contributes to rates of post-operative morbidity between
20-30% and rates of hospital readmission of 10-15% after primary surgical management (5,
6).
Both postoperative morbidity and hospital readmission in cancer patients prolong surgical
recovery, delay vital adjuvant treatment, increase overall health care costs and can have a
negative psychosocial impact on the patient and her family (7, 8). The factors that contribute
to surgical outcomes are multifactorial. Efforts to identify discrete predictive factors,
including frailty measures, have largely focused on medical comorbidity and patient
characteristics as assessed and interpreted by health care providers (9-11). Data on the
relationship between patient-reported outcomes – information provided directly from the
patient, without interpretation or modification – and surgical outcomes is limited.
Quality of life (QoL) assessments are a form of patient-reported outcomes, and have been
validated in assessing disease burden, treatment, and prognosis across a spectrum of cancer
sites (12-14). These scores are derived from QoL surveys, which are designed to measure
physical, functional, social and/or emotional well-being domains. Within gynecologic
oncology, specifically in women with ovarian cancer, QoL scores are predictive of disease
status, chemotherapy toxicity, and overall survival(12, 13, 15). The strongest associations
have been found within physical and functional domains. In two large Gynecologic
Oncology Group (GOG) chemotherapy trials, women in the lowest quartile of physical
wellbeing scores had decreased overall survival(12, 15). In colon cancer patients undergoing
surgery, preoperative patient-reported measures of poor functional status have been
associated with postoperative morbidity and mortality, with lower scores being associated
with increased risk (16-18). Such baseline factors that are found to predict poor surgical
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outcomes would represent new targets for intervention to improve the quality of surgical
recovery, avoid delays in adjuvant therapy, and decrease cancer care costs.
Our primary study objective was to explore the association between preoperative, baseline
QoL domain scores and postoperative morbidity and hospital readmission in gynecologic
oncology patients. We hypothesized that worse QoL scores would be associated with poor
surgical outcomes and this relationship would be strongest within the functional and
physical wellbeing domains.
Methods
Study Design, Enrollment, and Data Collection
We conducted an analysis of data prospectively collected for a large hospital-based
observational cohort. The Health Registry/Cancer Survivorship Cohort (HR/CSC) is an
institutional review board approved University of North Carolina (UNC) Health Care
registry of cancer patients that integrates a comprehensive database of clinical,
epidemiological, and interview data, with repositories of biologic specimens and tumor
tissue. Patients are identified and recruited through UNC Health Care oncology outpatient
clinics with the following eligibility criteria: age 18 years or older; North Carolina mailing
address; and English or Spanish proficiency. Patients who are unable to provide informed
consent or participate in interview questionnaires are excluded. For this analysis, eligibility
was further restricted to HR/CSC patients recruited through the gynecologic oncology
clinics, who completed the baseline interview prior to any cancer treatments, and had
documented 30 day post-operative follow up.
Interviews were conducted within 2 weeks of enrollment by trained staff using a computer-
assisted telephone interview software tool specifically developed for the HR/CSC. Interview
questionnaire topics include medical and social histories, and general and cancer-specific
health assessments. The following structured and validated questionnaires were included in
the analysis: Functional Assessment of Cancer Therapy - General Population (FACT-GP),
NIH Patient Reported Outcomes Measurement Information System (PROMIS©) global
mental (GMH) and physical health (GPH), a modified Work Ability Index, PG-SGA
(Patient Generated – Subjective Global Assessment), cancer-specific FACTs (Endometrial –
En, Ovarian – O, Vaginal/Vulvar – V, Cervical – Cx). The FACT-GP version 4 is a 21-item
scale that measures health related QoL using four subscales: physical (PWB), functional
(FWB), emotional (EWB), and social (SWB) wellbeing. The cancer-specific FACT scales
include the FACT-GP in addition to multi-item subscales that measure cancer site-specific
symptoms(19-22). The PROMIS© v1.0 global is a 10-item scale that measures the domains
of fatigue, physical function, pain, emotional distress, and social health(23). The modified
work ability index includes a subset of questions from the original scale, designed to assess
work ability compared to lifetime best, in relation to mental and physical demands, and sick
leave(24). The specific question analyzed for this study was, “Assume that your ability to
work at its best has a value of 10 points and 0 means that you cannot currently work at all.
How many points would you give your current ability to work?” with a 0 – 10 scale
response. The PG-SGA is a measure of overall functional status on a 5 tier scale, mirroring
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the Eastern Cooperative Oncology Group (ECOG) performance status ratings(25), but from
the patient's perspective(26).
Patient age, self-reported race/ethnicity, and employment status were abstracted from the
HR/CSC baseline interview. The electronic medical record was reviewed (physician,
nursing, and case management staff documentation) to abstract clinical data at the time of
new patient visit (BMI, co-morbid conditions, mental health history, cancer site) and during
the 30 day post-operative follow up window (surgical approach, intra/post-operative
complications, discharge location, unplanned clinic or emergency room visits, readmission,
and adjuvant treatment. Insurance status, at the time of new patient visit, was also abstracted
from the medical record. All medical record data was limited to encounters at our institution.
The medical record data file was then merged with the HR/CSC demographic and QoL data,
using an honest broker model. The HR/CSC subsequently provided a de-identified data set
for analysis.
Statistical Analysis
Summary statistics were generated using simple frequencies for categorical variables and
mean/medians for continuous variables. Composite variables of major medical comorbidity,
mental health diagnoses, and post-operative morbidity were created. The major comorbidity
variable included notation in the record for at least one of these conditions: diabetes,
pulmonary disease (chronic obstructive pulmonary disease, restrictive lung disease, home
oxygen requirement), cardiac disease (congestive heart failure, history of MI, coronary
artery disease), immunocompromised states (HIV, chronic steroid use), and chronic kidney
disease. For the composite mental health variable, we combined any notated diagnosis of
anxiety, depression, and chronic pain. Surgical morbidity was divided into intraoperative
complications (bladder, ureteral, vascular, nerve, and GI injury) and post-operative
complications (thromboembolic events, abscesses, cardiac event, renal insufficiency,
pulmonary events, organ injury, wound infection, wound opening, ileus, blood transfusion,
urinary tract infection). QoL scores were analyzed continuously and by 5-point increments
in relation to two outcomes: post-operative morbidity and hospital readmission (both 30 day
post-operative measures). The 5-point increment was chosen due to the minimally important
difference in most scale measures of 2-3 points (18-21). QoL scores were also treated as the
outcome and compared between patients who did and did not experience postoperative
morbidity and/or hospital readmission (analysis groups). Due to the modification of the
work ability index, no summary score could be generated and analyzed, therefore a simple
comparison of median responses to the selected question was performed between the
analysis groups. Only employed patients had recorded responses for this question. Baseline
characteristics between analysis groups were compared using Fisher's exact tests for
categorical variables, and Student's t-tests for continuous variables. The relationship
between the various QoL domains and post-operative outcomes were evaluated using
univariable and multivariable linear and logistic regression models.
We included factors in the multivariable analysis if they were identified clinically and
known to directly contribute to postoperative outcomes and if they differed substantially
between the analysis groups. Established risk factors considered to impact post-operative
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morbidity were age, BMI, minimally invasive surgical approach, and major medical
comorbidity (composite variable). The two factors considered to impact 30-day readmission
were insurance status and vulvar surgery. Insurance status was considered because
uninsured patients may require admission to access services that insured patients could
receive as outpatients, thus increasing their risk of readmission. Vulvar surgery was
considered because vulvar procedures have a significantly higher risk of late wound
complications compared to abdominal surgery (1), and this could result in higher
readmission rates compared to the other cancer sites. Using linear regression, multivariable
adjusted means were calculated, and using logistic regression odds ratios were calculated
and a graph of predicted probabilities was produced.
Results
Descriptive
Of 182 gynecologic oncology patients enrolled in the HR/CSC, there were 152 who met
inclusion criteria and formed the study cohort. Of the 30 excluded, 27 did not complete
baseline interviews (refusal (n=20), contacted after surgery (n=6), incomplete interview
(n=1)) and 3 had surgery performed at outside facilities). Of the study cohort, 148/152
underwent surgical treatment and 4 received primary chemotherapy or radiation. The 4
patients treated with primary chemotherapy and/or radiation had advanced cervical (n=2),
vulvar (n=1), and unspecified gynecologic (n=1) cancer and were excluded from the surgical
outcomes analysis. There were no patients with dual primary cancer sites. Median age was
58.9 (range 28 – 90, SD 13.0). Most patients were obese (BMI ≥ 30). The cohort had a
median BMI of 33.5 (range 18 – 62, SD 8.7). There was substantial racial, economic, and
social diversity (Table 1). There were 44 patients (29.0%) with no medical comorbidity, 65
(42.7%) with a non-major medical comorbidity, and 43 (28.3%) with major medical
comorbidity (as defined by the composite variable). With regard to mental health, 39
patients (25.7%) had diagnoses of depression, anxiety, or chronic pain. All gynecologic
cancer sites and stages were represented, in addition to 3 patients with suspected ovarian
cancer, who underwent standard debulking surgery, with final pathology resulting with
gastrointestinal primary malignancy (Table 1). Given that their surgical procedure was
identical to the ovarian cancer patients, we included them in the analysis.
A range of surgical procedures was performed, with a fairly even distribution between
minimally invasive and traditional open surgery (Table 2, Supplementary Table 1).
Postoperative morbidity was common, with 25% of patients experiencing major and/or
minor complications. Most patients with a complication experienced ≥ 1 event (Table 2,
Supplementary Table 2). Intensive care unit use, discharge to a subacute or acute
rehabilitation facility, and death, were rare (Table 2). After outpatient procedure or
discharge from an inpatient procedure, 33 (22.3%) of patients required unanticipated health
care resources defined as unplanned clinic or emergency room visits. There was only 1
patient with an emergency room visit who was not subsequently admitted to the hospital.
Following primary surgical management, 94 (63.5%) of patients were assigned to receive
adjuvant therapy, of whom 74 (78.8%) had documented treatment dates. The reasons for the
absence of documented dates of treatment were: loss to follow up (N=4); transfer of care
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with no further documentation (N=4); patient preference against treatment (N=9); treatment
delay secondary to post-operative complications (N=2) and unknown (N=1).
Univariable Analyses
Several preoperative QoL scores were different between patients who did and did not
experience postoperative morbidity and/or hospital readmission. In all cases of difference,
mean QoL scores of the postoperative morbidity and hospital readmission groups were
lower, indicating worse QoL (Table 3). Mean total FACT-GP scores differed between
patients who experienced post-operative morbidity and those who did not (74.7 vs 81.5,
p=0.05). This was largely driven by the differences in the mean subscale of functional
wellbeing (15.3 vs 18.7, p=.01). With examination of hospital readmission groups, the
overall FACT-GP mean scores also differed, driven by the differing physical (17.2 vs 22.3,
p=.003) and functional (12.8 vs 18.5, p=.002) wellbeing subscales. Mean cancer-specific
FACT-En, FACT-Cx, and FACT-V scores also differed with lower scores in the
postoperative morbidity and readmission groups, with the largest group – Uterine cancer
patients under the FACT-En -- reaching statistical significance (113.3 vs 140.7, p=.001) for
association with readmission. The FACT-Ovarian score relationship was reversed with
regard to postoperative morbidity (high scores in the postoperative morbidity group). The
readmission relationship was consistent with the other survey instruments. Readmitted
patients had lower mean PROMIS global mental and physical health scores. In comparing
the responses from the overall work ability question, from the modified Work Ability Index,
the median response for the readmission group (scale 0 -10) was 4.7 (IQR 1.5 – 8.0)
compared to a median response of 8.4 (IQR 7.6 -9) in the group that was not readmitted
(p=0.002).
Adjusted (Multivariable) analyses
Of the identified potential adjustment factors, only surgical route differed significantly by
post-operative morbidity group. There were 26/37 laparotomies (70.3%) in the post-
operative morbidity group, and 44/67 (39.6%) in the group without post-operative
morbidity. Age, BMI, medical comorbidity, mental health diagnoses, and surgical history
were similar between the groups. Table 4 shows the risk odds ratio from the multivariable
logistic regression model, adjusting for surgical route, for each 1-point decrease in score.
The FWB score ranges from 0 – 25. Based on this model each 5-point increase corresponds
to a 27% decrease in the odds of postoperative morbidity. Given the relationship between
mental health diagnoses and quality of life, we also performed an adjusted analysis for
anxiety, depression, and chronic pain. With this adjustment, post-operative morbidity
patients still had mean FWB scores 3.25 points lower than patients without postoperative
morbidity (p=0.02). There were no other domain scores that remained significantly
associated with postoperative morbidity when adjusted for surgical route or anxiety/
depression/chronic pain.
For the 30 day readmission analysis, neither of the identified adjustment factors (insurance
status, vulvar surgery) differed statistically; however, the distributions were not balanced.
For insurance status, there were no Medicare/Medicaid patients in the readmitted group
compared to 12 in the group without readmission. With regard to vulvar surgery, there were
Doll et al. Page 6






















3/17 (17.7%) in the readmission group and 5/131 (3.8%) in the group without readmission.
Therefore, both variables were considered as confounders. Age, BMI, medical comorbidity,
and surgical route did not differ between the readmission groups. Given the number of
readmission events (N=17), we could only account for a single covariate in the model,
which was adjusting for insurance type. The FACT-GP, FWB, PWB, PROMIS global
physical health, and PG-SGA scores were all significantly associated with 30-day
readmission (Table 4). The strongest association among the subscales was with FWB. Each
1 point increase in FWB score, resulted in a 10% decrease in the odds of 30 day
readmission. Evaluated in 5-point increments, this corresponded to a 40% decrease in the
odds. Each one unit increase in PG-SGA assessment was associated with 1.89 times the
odds of readmission (OR 1.89, 95%CI 1.14 – 3.16, p=0.012). In this scale, increasing score
represents decreasing functional ability. Endometrial cancer patients were the largest cancer-
site subset, and the corresponding FACT-En was also associated with 30 day readmission
(OR 1.04, 95%CI 1.01 - 1.06). We performed the same set of analyses, adjusting for vulvar
surgery and again for bowel procedures, with similar results (not shown). Finally, we
adjusted for mental health diagnoses, and the trend in mean QoL scores remained the same,
with lower scores associated with 30 day readmission (data not shown). The predicted
probabilities of 30-day readmission by FWB subscale are shown in Figure 1.
Discussion
In an observational cohort study of gynecologic oncology patients, our analysis
demonstrates that baseline, preoperative QoL scores are associated with postoperative
surgical outcomes and hospital readmission. Lower scores in physical and functional
domains are associated with increased risk of postoperative morbidity and 30 day
readmission.
It is the goal of all cancer surgeons to both proceed with a successful operation and
minimize perioperative complications that lead to prolonged recovery and may delay
subsequent adjuvant cancer therapy. The quality of surgical recovery is equally as important
as the quality of the surgical operation. In cancer patients, the quality surgical recovery has
lasting effects. Surgery is frequently the first step in multi-modality treatment with the goal
of curing the cancer. It follows, then, that the relative ease (quality) with which a patient
recovers can impact his or her physical, functional, and emotional resilience for adjuvant
therapies to come. Even for those who do not require adjuvant therapy, post-operative
complications can have long lasting physical, social, emotional and financial implications
for the patient and her family.
QoL domain scores are patient-reported assessments of physical, functional, and emotional
resilience. These scores are known to be predictive of treatment toxicity and survival in
ovarian cancer patients undergoing chemotherapy(12, 15). Within the clinical trial GOG
172, patients with the lowest quartile of physical wellbeing domain scores were more likely
to die (OR 1.81, 95%CI 1.2-2.7) and for each mean point increase in this score, there was a
20% decrease in death rate. In our study of ovarian, endometrial, cervical, and vulvar cancer
patients, we have found that for every 5-point increase in functional wellbeing score, there is
a 27% decrease in the odds of postoperative morbidity and a 40% decrease in the odds of
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readmission. Among several different assessment tools we analyzed, we show that this
relationship was most consistent among measurements of physical and functional wellbeing.
This consistency implies that our patients' self-assessed physical and functional ability are
important contributing factors to the quality of their surgical recovery.
Our findings have several implications. Patient reported measures may be just as important
as physician assessments of surgical risk. This additional information on a patient's global
status could help improve informed consent and shared decision making for risky surgical
procedures, especially in the emotional context of a new cancer diagnosis. For physicians,
improving the accuracy of surgical risk assessment would also aid greatly in patient
selection for surgery. Finally, in the same way we view medical risk factors, poor nutritional
status, and polypharmacy (27-29), these physical and functional deficits can be targets for
intervention. Occupational and physical therapy are designed to improve functional and
physical status and their use for surgical cancer patients in the pre-operative and/or
immediate postoperative setting, to our knowledge, has not be explored.
Our study is strengthened by its observational design, capturing a racially and economically
diverse patient population. As these patients were not defined by enrollment into a clinical
trial, we feel these results can be translated to a wider population not captured in cooperative
group trials. Our cohort also had a complication and readmission rate comparable to recently
published studies of gynecologic oncology populations, furthering the generalizability(1-6).
Our results represent preliminary evidence and must be verified with additional, larger
prospective studies. We were limited by the degree of documentation in the medical record,
although we reviewed physician, nursing, and ancillary staff notes. Our study involved
multiple cancer sites within gynecologic oncology and a variety of surgical procedures,
introducing many potential confounders. Our sample size limited our ability to create
complex multivariable models and our results for cancer-site specific instruments for
cervical, ovarian, and vulvar cancer are very limited by the small number of outcomes
within each group. However, we could account for the multiple cancer sites and routes of
surgery partially, by evaluating both the largest subgroup (endometrial cancer) and by
removing the highest risk site (vulvar cancer). With both of these sensitivity analyses, the
QoL score relationship remained significant and consistent with findings among other
populations (18, 23, 24). We note also that these QoL measures were gathered in the context
of a larger cohort study, with a baseline hour-long interview incorporating other patient-
reported tools. This format would not be appropriate for general clinical care. Given the
versatility of survey administration (in person, telephone, written), and the increasing ability
to communicate with patients electronically, we can conceive of a web-based platform of
evaluation where patients could directly enter information and reports could be generated for
the surgeon, alongside radiological and pathology data.
Improved surgical risk assessment improves patient counseling and informed consent,
enhances surgeon decision making through improved patient selection, and provides novel
targets for pre- and post-operative intervention. In cancer patients, this additional
information could lend weight to crucial decisions between primary medical or surgical
management. We are currently conducting a prospective observational study, administering
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QoL assessments preoperatively, and at 1, 3 and 6 months postoperatively to verify these
results and explore the short and long-term quality of life trends after surgery. If verified,
this will mean that it is possible to identify a subset of surgical patients, who may be at high
risk for morbidity, and therefore candidates for pre or post-operative functional intervention.
This is an important first step in a patient-centered approach to improve the quality of
surgical recovery in cancer care.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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1. Patient-reported pre-operative QoL measures are associated with postoperative
outcomes in gynecologic oncology patients.
2. Measures of lower functional and physical ability are most strongly correlated
with risk of post-operative morbidity and hospital readmissions.
3. Identifying QoL deficits pre-operatively can improve patient selection and
counseling, and targeting of high-risk patients for pre- and post-operative
intervention.
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Figure 1. Predicted probabilities for 30 Day Readmission by Pre-operative Functional Well
Being Score
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Table 1
Overall Study Cohort Characteristics
Variable N %
Age 18 - 30 years 3 2.0
31 – 50 years 30 19.7
51 – 70 years 92 60.5
Over 70 years 27 17.8
BMI
Under 25.0 27 17.8
25.0 – 29.9 27 17.8
30.0 – 39.9 68 44.7











Medicare only 7 4.6
Medicaid 5 3.2
Employment
Part Time 24 15.8








Prior Laparotomy 35 23.0
Diabetes2 30 19.7
Pulmonary Disease2 4 2.6
HTN 75 49.3
Chronic Kidney Disease2 2 1.3
Cardiac Disease (CHF/CAD/MI) 2 15 9.9
Arthritis 13 8.6
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Variable N %
Immunocompromise2 2 1.3
History of Cancer 28 18.4
Substance Abuse 18 11.8
Major Comorbidity3 43 28.3
Mental Health
Substance Abuse 18 11.8
Depression 24 15.8
Anxiety 18 11.8






Gyn NOS4 3 2.0
GI5 3 2.0
Cancer Stage
Stage I - II 98 64.5
Stage III - IV 46 30.3
Unstaged 8 5.3
1
NIH defined self-reported race/ethnicity.
2
Indicates inclusion in Major Comorbidity composite variable.
3
Indicates inclusion in Major Comorbidity composite variable.
4
Gyn Not Otherwise Specified – Either gynecologic cancer of unknown origin (2) or dual gynecologic primary(1).
5
Gastrointestinal – 3 patients with suspected ovarian cancer that had primary GI malignancy on final pathology.
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Table 2









Postoperative Course (30 Day)
Intra op complication3 14 9.5
Postop morbidity4 37 25.0





Acute Rehab6 1 0.7
Unplanned Post-op Resource Use (30 Day)
Clinic Visit 9 6.1




Not Recommended 54 36.5
Treatment Started 74 78.8%




Minimally invasive surgery including laparoscopic, robotic, or hysteroscopic approach
3
Includes bladder, ureteral, vascular, nerve, and GI injury
4
Includes VTE/PE, Abscesses, Cardiac event, renal insufficiency, pulmonary events, organ injury, wound infection, wound opening, ileus, blood
transfusion, urinary tract infection
5
Skilled nursing facility or Sub-acute rehabilitation facility
6
Acute inpatient rehabilitation facility
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Table 4
Odds Ratio of Surgical Outcomes by Preoperative Quality of Life Assessment
Odds Ratio p-value 95% Confidence Interval
Postoperative Morbidity1
FWB 1.07 0.01 1.01 – 1.21
Hospital Readmission2
FACT-GP 1.03 0.03 1.01, 1.06
FWB 1.11 0.006 1.03, 1.19
PWB 1.10 0.008 1.02, 1.18
PROMIS Global 1.07 0.04 1.01, 1.05
Physical Health FACT-En3 1.04 0.005 1.01, 1.06
Odds ratios are reported for a 1-point decrease for each scale. Lower scores are associated with increased odds of postoperative morbidity and/or
hospital readmission.
1
Adjusted for surgical route
2
Adjusted for insurance status
3
Endometrial cancer patients only, N=86
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